In this study, we further explored whether Rg1 regulates the occurrence and development of NASH by regulating autophagy and pyroptosis through miRNA targeting ATG2B, providing a strong theoretical and experimental basis for new NASH therapies. The gene discussed is ATG2B; the disease is metabolic dysfunction-associated steatohepatitis.